Thyroid hormone is required for the phenotype transitions induced by the pharmacological inhibition of calcineurin in adult soleus muscle of rats
1 Centre de Recherches du Service de Santé des Armées, La Tronche, Cedex; and 2 Inserm U769, Université Paris-Sud, Châtenay-Malabry, France Submitted 16 March 2007 ; accepted in final form 16 October 2007 The present experiment was designed to examine the effects of hypothyroidism and calcineurin in...
Gespeichert in:
Veröffentlicht in: | American journal of physiology: endocrinology and metabolism 2008-01, Vol.294 (1), p.E69-E77 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | E77 |
---|---|
container_issue | 1 |
container_start_page | E69 |
container_title | American journal of physiology: endocrinology and metabolism |
container_volume | 294 |
creator | Koulmann, Nathalie Bahi, Lahoucine Ribera, Florence Sanchez, Herve Serrurier, Bernard Chapot, Rachel Peinnequin, Andre Ventura-Clapier, Renee Bigard, Xavier |
description | 1 Centre de Recherches du Service de Santé des Armées, La Tronche, Cedex; and 2 Inserm U769, Université Paris-Sud, Châtenay-Malabry, France
Submitted 16 March 2007
; accepted in final form 16 October 2007
The present experiment was designed to examine the effects of hypothyroidism and calcineurin inhibition induced by cyclosporin A (CsA) administration on both contractile and metabolic soleus muscle phenotypes, with a novel approach to the signaling pathway controlling mitochondrial biogenesis. Twenty-eight rats were randomly assigned to four groups, normothyroid, hypothyroid, and orally treated with either CsA (25 mg/kg, N-CsA and H-CsA) or vehicle (N-Vh and H-Vh), for 3 wk. Muscle phenotype was estimated by the MHC profile and activities of oxidative and glycolytic enzymes. We measured mRNA levels of the peroxisome proliferator-activated receptor- coactivator-1 (PGC-1 ), the major regulator of mitochondrial content. We also studied the expression of the catalytic A-subunit of calcineurin (CnA) both at protein and transcript levels and mRNA levels of modulatory calcineurin inhibitor proteins (MCIP)-1 and -2, which are differentially regulated by calcineurin activity and thyroid hormone, respectively. CsA-administration induced a slow-to-fast MHC transition limited to the type IIA isoform, which is associated with increased oxidative capacities. Hypothyroidism strongly decreased both the expression of fast MHC isoforms and oxidative capacities. Effects of CsA administration on muscle phenotype were blocked in conditions of thyroid hormone deficiency. Changes in the oxidative profile were strongly related to PGC-1 changes and associated with phosphorylation of p38 MAPK. Calcineurin and MCIPs mRNA levels were decreased by both hypothyroidism and CsA without additive effects. Taken together, these results suggest that adult muscle phenotype is primarily under the control of thyroid state. Physiological levels of thyroid hormone are required for the effects of calcineurin inhibition on slow oxidative muscle phenotype.
muscle phenotype; hypothyroidism; myosin heavy chain; oxidative capacities
Address for reprint requests and other correspondence: N. Koulmann, Département des facteurs humains, Centre de recherches du service de santé des armées, BP 87-38702 La Tronche Cedex, France (e-mail: nkoulmann{at}crssa.net ) |
doi_str_mv | 10.1152/ajpendo.00173.2007 |
format | Article |
fullrecord | <record><control><sourceid>proquest_highw</sourceid><recordid>TN_cdi_proquest_miscellaneous_20865195</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70194482</sourcerecordid><originalsourceid>FETCH-LOGICAL-c482t-a6802f4648cba85bfd7841527d81797c2b4ac3cd6abb19713cce3b7af7dbc3293</originalsourceid><addsrcrecordid>eNqFks1u1DAUhS0EokPhBVggiwUrZvBPnJ9lVbUUaSQ2w9pybKfxyLFTO6bkMXhjnE5aEEJiZcn3O9f3-B4A3mK0w5iRT-I4aqf8DiFc0R1BqHoGNrlAtpgx9hxsEG7oFtdFcwZexXhEmWAFeQnOcNVUmGG2AT8P_Ry8UbD3YfBOQxNh0HfJBK1g5wOceg3HXjs_zaOGUxAumsl4F6FxKslMtfMKiTAI6a2_NVLYXO5N-4BC38F8I43TKRiXK1CoZCcYvdUpwiFFafVCBTHF1-BFJ2zUb9bzHHy7vjpc3mz3Xz9_ubzYb2VRk2kryhqRriiLWraiZm2nqrrI5itVL-4kaQshqVSlaFuc3VIpNW0r0VWqlZQ09Bx8PPXtheVjMIMIM_fC8JuLPTcu6jBwhGjNWFN9xxn_cMLH4O-SjhMfTJTaWuG0T5FX-bOLPNl_QYLqkuGGZfD9X-DRp-CyZ04oobig5fIsOUEy-BiD7p5GxYgvKeBrCvhDCviSgix6t3ZO7aDVb8m69gzUq3dz29_nXfOxn6NZdjfz62TtQf-YHjuTpuCYX5UNH1X3x7f9Q_o4y5OE_gKT0dbR</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>232314361</pqid></control><display><type>article</type><title>Thyroid hormone is required for the phenotype transitions induced by the pharmacological inhibition of calcineurin in adult soleus muscle of rats</title><source>MEDLINE</source><source>American Physiological Society</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Koulmann, Nathalie ; Bahi, Lahoucine ; Ribera, Florence ; Sanchez, Herve ; Serrurier, Bernard ; Chapot, Rachel ; Peinnequin, Andre ; Ventura-Clapier, Renee ; Bigard, Xavier</creator><creatorcontrib>Koulmann, Nathalie ; Bahi, Lahoucine ; Ribera, Florence ; Sanchez, Herve ; Serrurier, Bernard ; Chapot, Rachel ; Peinnequin, Andre ; Ventura-Clapier, Renee ; Bigard, Xavier</creatorcontrib><description>1 Centre de Recherches du Service de Santé des Armées, La Tronche, Cedex; and 2 Inserm U769, Université Paris-Sud, Châtenay-Malabry, France
Submitted 16 March 2007
; accepted in final form 16 October 2007
The present experiment was designed to examine the effects of hypothyroidism and calcineurin inhibition induced by cyclosporin A (CsA) administration on both contractile and metabolic soleus muscle phenotypes, with a novel approach to the signaling pathway controlling mitochondrial biogenesis. Twenty-eight rats were randomly assigned to four groups, normothyroid, hypothyroid, and orally treated with either CsA (25 mg/kg, N-CsA and H-CsA) or vehicle (N-Vh and H-Vh), for 3 wk. Muscle phenotype was estimated by the MHC profile and activities of oxidative and glycolytic enzymes. We measured mRNA levels of the peroxisome proliferator-activated receptor- coactivator-1 (PGC-1 ), the major regulator of mitochondrial content. We also studied the expression of the catalytic A-subunit of calcineurin (CnA) both at protein and transcript levels and mRNA levels of modulatory calcineurin inhibitor proteins (MCIP)-1 and -2, which are differentially regulated by calcineurin activity and thyroid hormone, respectively. CsA-administration induced a slow-to-fast MHC transition limited to the type IIA isoform, which is associated with increased oxidative capacities. Hypothyroidism strongly decreased both the expression of fast MHC isoforms and oxidative capacities. Effects of CsA administration on muscle phenotype were blocked in conditions of thyroid hormone deficiency. Changes in the oxidative profile were strongly related to PGC-1 changes and associated with phosphorylation of p38 MAPK. Calcineurin and MCIPs mRNA levels were decreased by both hypothyroidism and CsA without additive effects. Taken together, these results suggest that adult muscle phenotype is primarily under the control of thyroid state. Physiological levels of thyroid hormone are required for the effects of calcineurin inhibition on slow oxidative muscle phenotype.
muscle phenotype; hypothyroidism; myosin heavy chain; oxidative capacities
Address for reprint requests and other correspondence: N. Koulmann, Département des facteurs humains, Centre de recherches du service de santé des armées, BP 87-38702 La Tronche Cedex, France (e-mail: nkoulmann{at}crssa.net )</description><identifier>ISSN: 0193-1849</identifier><identifier>EISSN: 1522-1555</identifier><identifier>DOI: 10.1152/ajpendo.00173.2007</identifier><identifier>PMID: 17971515</identifier><identifier>CODEN: AJPMD9</identifier><language>eng</language><publisher>United States: American Physiological Society</publisher><subject>Age Factors ; Animals ; Biochemistry, Molecular Biology ; Calcineurin ; Calcineurin - genetics ; Calcineurin - metabolism ; Calcineurin Inhibitors ; Catalytic Domain ; Cyclosporine ; Cyclosporine - blood ; Cyclosporine - pharmacology ; Electrophoresis, Polyacrylamide Gel ; Enzyme Inhibitors ; Enzyme Inhibitors - blood ; Enzyme Inhibitors - pharmacology ; Gene expression ; Genotype & phenotype ; Growth hormones ; Hypothyroidism ; Hypothyroidism - metabolism ; Life Sciences ; Male ; Metabolism ; Muscle Proteins ; Muscle Proteins - genetics ; Muscle Proteins - metabolism ; Muscle, Skeletal ; Muscle, Skeletal - drug effects ; Muscle, Skeletal - enzymology ; Myosin Heavy Chains ; Myosin Heavy Chains - metabolism ; p38 Mitogen-Activated Protein Kinases ; p38 Mitogen-Activated Protein Kinases - metabolism ; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha ; Phenotype ; Phosphorylation ; Proteins ; Rats ; Rats, Wistar ; RNA, Messenger ; RNA, Messenger - metabolism ; RNA-Binding Proteins ; RNA-Binding Proteins - genetics ; RNA-Binding Proteins - metabolism ; Rodents ; Thyroid Hormones ; Thyroid Hormones - metabolism ; Transcription Factors ; Transcription Factors - genetics ; Transcription Factors - metabolism</subject><ispartof>American journal of physiology: endocrinology and metabolism, 2008-01, Vol.294 (1), p.E69-E77</ispartof><rights>Copyright American Physiological Society Jan 2008</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c482t-a6802f4648cba85bfd7841527d81797c2b4ac3cd6abb19713cce3b7af7dbc3293</citedby><cites>FETCH-LOGICAL-c482t-a6802f4648cba85bfd7841527d81797c2b4ac3cd6abb19713cce3b7af7dbc3293</cites><orcidid>0000-0002-6116-5795 ; 0000-0002-7488-4123</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,3026,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17971515$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://inserm.hal.science/inserm-00385597$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Koulmann, Nathalie</creatorcontrib><creatorcontrib>Bahi, Lahoucine</creatorcontrib><creatorcontrib>Ribera, Florence</creatorcontrib><creatorcontrib>Sanchez, Herve</creatorcontrib><creatorcontrib>Serrurier, Bernard</creatorcontrib><creatorcontrib>Chapot, Rachel</creatorcontrib><creatorcontrib>Peinnequin, Andre</creatorcontrib><creatorcontrib>Ventura-Clapier, Renee</creatorcontrib><creatorcontrib>Bigard, Xavier</creatorcontrib><title>Thyroid hormone is required for the phenotype transitions induced by the pharmacological inhibition of calcineurin in adult soleus muscle of rats</title><title>American journal of physiology: endocrinology and metabolism</title><addtitle>Am J Physiol Endocrinol Metab</addtitle><description>1 Centre de Recherches du Service de Santé des Armées, La Tronche, Cedex; and 2 Inserm U769, Université Paris-Sud, Châtenay-Malabry, France
Submitted 16 March 2007
; accepted in final form 16 October 2007
The present experiment was designed to examine the effects of hypothyroidism and calcineurin inhibition induced by cyclosporin A (CsA) administration on both contractile and metabolic soleus muscle phenotypes, with a novel approach to the signaling pathway controlling mitochondrial biogenesis. Twenty-eight rats were randomly assigned to four groups, normothyroid, hypothyroid, and orally treated with either CsA (25 mg/kg, N-CsA and H-CsA) or vehicle (N-Vh and H-Vh), for 3 wk. Muscle phenotype was estimated by the MHC profile and activities of oxidative and glycolytic enzymes. We measured mRNA levels of the peroxisome proliferator-activated receptor- coactivator-1 (PGC-1 ), the major regulator of mitochondrial content. We also studied the expression of the catalytic A-subunit of calcineurin (CnA) both at protein and transcript levels and mRNA levels of modulatory calcineurin inhibitor proteins (MCIP)-1 and -2, which are differentially regulated by calcineurin activity and thyroid hormone, respectively. CsA-administration induced a slow-to-fast MHC transition limited to the type IIA isoform, which is associated with increased oxidative capacities. Hypothyroidism strongly decreased both the expression of fast MHC isoforms and oxidative capacities. Effects of CsA administration on muscle phenotype were blocked in conditions of thyroid hormone deficiency. Changes in the oxidative profile were strongly related to PGC-1 changes and associated with phosphorylation of p38 MAPK. Calcineurin and MCIPs mRNA levels were decreased by both hypothyroidism and CsA without additive effects. Taken together, these results suggest that adult muscle phenotype is primarily under the control of thyroid state. Physiological levels of thyroid hormone are required for the effects of calcineurin inhibition on slow oxidative muscle phenotype.
muscle phenotype; hypothyroidism; myosin heavy chain; oxidative capacities
Address for reprint requests and other correspondence: N. Koulmann, Département des facteurs humains, Centre de recherches du service de santé des armées, BP 87-38702 La Tronche Cedex, France (e-mail: nkoulmann{at}crssa.net )</description><subject>Age Factors</subject><subject>Animals</subject><subject>Biochemistry, Molecular Biology</subject><subject>Calcineurin</subject><subject>Calcineurin - genetics</subject><subject>Calcineurin - metabolism</subject><subject>Calcineurin Inhibitors</subject><subject>Catalytic Domain</subject><subject>Cyclosporine</subject><subject>Cyclosporine - blood</subject><subject>Cyclosporine - pharmacology</subject><subject>Electrophoresis, Polyacrylamide Gel</subject><subject>Enzyme Inhibitors</subject><subject>Enzyme Inhibitors - blood</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Gene expression</subject><subject>Genotype & phenotype</subject><subject>Growth hormones</subject><subject>Hypothyroidism</subject><subject>Hypothyroidism - metabolism</subject><subject>Life Sciences</subject><subject>Male</subject><subject>Metabolism</subject><subject>Muscle Proteins</subject><subject>Muscle Proteins - genetics</subject><subject>Muscle Proteins - metabolism</subject><subject>Muscle, Skeletal</subject><subject>Muscle, Skeletal - drug effects</subject><subject>Muscle, Skeletal - enzymology</subject><subject>Myosin Heavy Chains</subject><subject>Myosin Heavy Chains - metabolism</subject><subject>p38 Mitogen-Activated Protein Kinases</subject><subject>p38 Mitogen-Activated Protein Kinases - metabolism</subject><subject>Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha</subject><subject>Phenotype</subject><subject>Phosphorylation</subject><subject>Proteins</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>RNA, Messenger</subject><subject>RNA, Messenger - metabolism</subject><subject>RNA-Binding Proteins</subject><subject>RNA-Binding Proteins - genetics</subject><subject>RNA-Binding Proteins - metabolism</subject><subject>Rodents</subject><subject>Thyroid Hormones</subject><subject>Thyroid Hormones - metabolism</subject><subject>Transcription Factors</subject><subject>Transcription Factors - genetics</subject><subject>Transcription Factors - metabolism</subject><issn>0193-1849</issn><issn>1522-1555</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFks1u1DAUhS0EokPhBVggiwUrZvBPnJ9lVbUUaSQ2w9pybKfxyLFTO6bkMXhjnE5aEEJiZcn3O9f3-B4A3mK0w5iRT-I4aqf8DiFc0R1BqHoGNrlAtpgx9hxsEG7oFtdFcwZexXhEmWAFeQnOcNVUmGG2AT8P_Ry8UbD3YfBOQxNh0HfJBK1g5wOceg3HXjs_zaOGUxAumsl4F6FxKslMtfMKiTAI6a2_NVLYXO5N-4BC38F8I43TKRiXK1CoZCcYvdUpwiFFafVCBTHF1-BFJ2zUb9bzHHy7vjpc3mz3Xz9_ubzYb2VRk2kryhqRriiLWraiZm2nqrrI5itVL-4kaQshqVSlaFuc3VIpNW0r0VWqlZQ09Bx8PPXtheVjMIMIM_fC8JuLPTcu6jBwhGjNWFN9xxn_cMLH4O-SjhMfTJTaWuG0T5FX-bOLPNl_QYLqkuGGZfD9X-DRp-CyZ04oobig5fIsOUEy-BiD7p5GxYgvKeBrCvhDCviSgix6t3ZO7aDVb8m69gzUq3dz29_nXfOxn6NZdjfz62TtQf-YHjuTpuCYX5UNH1X3x7f9Q_o4y5OE_gKT0dbR</recordid><startdate>20080101</startdate><enddate>20080101</enddate><creator>Koulmann, Nathalie</creator><creator>Bahi, Lahoucine</creator><creator>Ribera, Florence</creator><creator>Sanchez, Herve</creator><creator>Serrurier, Bernard</creator><creator>Chapot, Rachel</creator><creator>Peinnequin, Andre</creator><creator>Ventura-Clapier, Renee</creator><creator>Bigard, Xavier</creator><general>American Physiological Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7TS</scope><scope>7U7</scope><scope>C1K</scope><scope>7TM</scope><scope>7X8</scope><scope>1XC</scope><scope>VOOES</scope><orcidid>https://orcid.org/0000-0002-6116-5795</orcidid><orcidid>https://orcid.org/0000-0002-7488-4123</orcidid></search><sort><creationdate>20080101</creationdate><title>Thyroid hormone is required for the phenotype transitions induced by the pharmacological inhibition of calcineurin in adult soleus muscle of rats</title><author>Koulmann, Nathalie ; Bahi, Lahoucine ; Ribera, Florence ; Sanchez, Herve ; Serrurier, Bernard ; Chapot, Rachel ; Peinnequin, Andre ; Ventura-Clapier, Renee ; Bigard, Xavier</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c482t-a6802f4648cba85bfd7841527d81797c2b4ac3cd6abb19713cce3b7af7dbc3293</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Age Factors</topic><topic>Animals</topic><topic>Biochemistry, Molecular Biology</topic><topic>Calcineurin</topic><topic>Calcineurin - genetics</topic><topic>Calcineurin - metabolism</topic><topic>Calcineurin Inhibitors</topic><topic>Catalytic Domain</topic><topic>Cyclosporine</topic><topic>Cyclosporine - blood</topic><topic>Cyclosporine - pharmacology</topic><topic>Electrophoresis, Polyacrylamide Gel</topic><topic>Enzyme Inhibitors</topic><topic>Enzyme Inhibitors - blood</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Gene expression</topic><topic>Genotype & phenotype</topic><topic>Growth hormones</topic><topic>Hypothyroidism</topic><topic>Hypothyroidism - metabolism</topic><topic>Life Sciences</topic><topic>Male</topic><topic>Metabolism</topic><topic>Muscle Proteins</topic><topic>Muscle Proteins - genetics</topic><topic>Muscle Proteins - metabolism</topic><topic>Muscle, Skeletal</topic><topic>Muscle, Skeletal - drug effects</topic><topic>Muscle, Skeletal - enzymology</topic><topic>Myosin Heavy Chains</topic><topic>Myosin Heavy Chains - metabolism</topic><topic>p38 Mitogen-Activated Protein Kinases</topic><topic>p38 Mitogen-Activated Protein Kinases - metabolism</topic><topic>Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha</topic><topic>Phenotype</topic><topic>Phosphorylation</topic><topic>Proteins</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>RNA, Messenger</topic><topic>RNA, Messenger - metabolism</topic><topic>RNA-Binding Proteins</topic><topic>RNA-Binding Proteins - genetics</topic><topic>RNA-Binding Proteins - metabolism</topic><topic>Rodents</topic><topic>Thyroid Hormones</topic><topic>Thyroid Hormones - metabolism</topic><topic>Transcription Factors</topic><topic>Transcription Factors - genetics</topic><topic>Transcription Factors - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Koulmann, Nathalie</creatorcontrib><creatorcontrib>Bahi, Lahoucine</creatorcontrib><creatorcontrib>Ribera, Florence</creatorcontrib><creatorcontrib>Sanchez, Herve</creatorcontrib><creatorcontrib>Serrurier, Bernard</creatorcontrib><creatorcontrib>Chapot, Rachel</creatorcontrib><creatorcontrib>Peinnequin, Andre</creatorcontrib><creatorcontrib>Ventura-Clapier, Renee</creatorcontrib><creatorcontrib>Bigard, Xavier</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Physical Education Index</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Nucleic Acids Abstracts</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>Hyper Article en Ligne (HAL) (Open Access)</collection><jtitle>American journal of physiology: endocrinology and metabolism</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Koulmann, Nathalie</au><au>Bahi, Lahoucine</au><au>Ribera, Florence</au><au>Sanchez, Herve</au><au>Serrurier, Bernard</au><au>Chapot, Rachel</au><au>Peinnequin, Andre</au><au>Ventura-Clapier, Renee</au><au>Bigard, Xavier</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Thyroid hormone is required for the phenotype transitions induced by the pharmacological inhibition of calcineurin in adult soleus muscle of rats</atitle><jtitle>American journal of physiology: endocrinology and metabolism</jtitle><addtitle>Am J Physiol Endocrinol Metab</addtitle><date>2008-01-01</date><risdate>2008</risdate><volume>294</volume><issue>1</issue><spage>E69</spage><epage>E77</epage><pages>E69-E77</pages><issn>0193-1849</issn><eissn>1522-1555</eissn><coden>AJPMD9</coden><abstract>1 Centre de Recherches du Service de Santé des Armées, La Tronche, Cedex; and 2 Inserm U769, Université Paris-Sud, Châtenay-Malabry, France
Submitted 16 March 2007
; accepted in final form 16 October 2007
The present experiment was designed to examine the effects of hypothyroidism and calcineurin inhibition induced by cyclosporin A (CsA) administration on both contractile and metabolic soleus muscle phenotypes, with a novel approach to the signaling pathway controlling mitochondrial biogenesis. Twenty-eight rats were randomly assigned to four groups, normothyroid, hypothyroid, and orally treated with either CsA (25 mg/kg, N-CsA and H-CsA) or vehicle (N-Vh and H-Vh), for 3 wk. Muscle phenotype was estimated by the MHC profile and activities of oxidative and glycolytic enzymes. We measured mRNA levels of the peroxisome proliferator-activated receptor- coactivator-1 (PGC-1 ), the major regulator of mitochondrial content. We also studied the expression of the catalytic A-subunit of calcineurin (CnA) both at protein and transcript levels and mRNA levels of modulatory calcineurin inhibitor proteins (MCIP)-1 and -2, which are differentially regulated by calcineurin activity and thyroid hormone, respectively. CsA-administration induced a slow-to-fast MHC transition limited to the type IIA isoform, which is associated with increased oxidative capacities. Hypothyroidism strongly decreased both the expression of fast MHC isoforms and oxidative capacities. Effects of CsA administration on muscle phenotype were blocked in conditions of thyroid hormone deficiency. Changes in the oxidative profile were strongly related to PGC-1 changes and associated with phosphorylation of p38 MAPK. Calcineurin and MCIPs mRNA levels were decreased by both hypothyroidism and CsA without additive effects. Taken together, these results suggest that adult muscle phenotype is primarily under the control of thyroid state. Physiological levels of thyroid hormone are required for the effects of calcineurin inhibition on slow oxidative muscle phenotype.
muscle phenotype; hypothyroidism; myosin heavy chain; oxidative capacities
Address for reprint requests and other correspondence: N. Koulmann, Département des facteurs humains, Centre de recherches du service de santé des armées, BP 87-38702 La Tronche Cedex, France (e-mail: nkoulmann{at}crssa.net )</abstract><cop>United States</cop><pub>American Physiological Society</pub><pmid>17971515</pmid><doi>10.1152/ajpendo.00173.2007</doi><orcidid>https://orcid.org/0000-0002-6116-5795</orcidid><orcidid>https://orcid.org/0000-0002-7488-4123</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0193-1849 |
ispartof | American journal of physiology: endocrinology and metabolism, 2008-01, Vol.294 (1), p.E69-E77 |
issn | 0193-1849 1522-1555 |
language | eng |
recordid | cdi_proquest_miscellaneous_20865195 |
source | MEDLINE; American Physiological Society; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
subjects | Age Factors Animals Biochemistry, Molecular Biology Calcineurin Calcineurin - genetics Calcineurin - metabolism Calcineurin Inhibitors Catalytic Domain Cyclosporine Cyclosporine - blood Cyclosporine - pharmacology Electrophoresis, Polyacrylamide Gel Enzyme Inhibitors Enzyme Inhibitors - blood Enzyme Inhibitors - pharmacology Gene expression Genotype & phenotype Growth hormones Hypothyroidism Hypothyroidism - metabolism Life Sciences Male Metabolism Muscle Proteins Muscle Proteins - genetics Muscle Proteins - metabolism Muscle, Skeletal Muscle, Skeletal - drug effects Muscle, Skeletal - enzymology Myosin Heavy Chains Myosin Heavy Chains - metabolism p38 Mitogen-Activated Protein Kinases p38 Mitogen-Activated Protein Kinases - metabolism Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha Phenotype Phosphorylation Proteins Rats Rats, Wistar RNA, Messenger RNA, Messenger - metabolism RNA-Binding Proteins RNA-Binding Proteins - genetics RNA-Binding Proteins - metabolism Rodents Thyroid Hormones Thyroid Hormones - metabolism Transcription Factors Transcription Factors - genetics Transcription Factors - metabolism |
title | Thyroid hormone is required for the phenotype transitions induced by the pharmacological inhibition of calcineurin in adult soleus muscle of rats |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-14T00%3A13%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_highw&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Thyroid%20hormone%20is%20required%20for%20the%20phenotype%20transitions%20induced%20by%20the%20pharmacological%20inhibition%20of%20calcineurin%20in%20adult%20soleus%20muscle%20of%20rats&rft.jtitle=American%20journal%20of%20physiology:%20endocrinology%20and%20metabolism&rft.au=Koulmann,%20Nathalie&rft.date=2008-01-01&rft.volume=294&rft.issue=1&rft.spage=E69&rft.epage=E77&rft.pages=E69-E77&rft.issn=0193-1849&rft.eissn=1522-1555&rft.coden=AJPMD9&rft_id=info:doi/10.1152/ajpendo.00173.2007&rft_dat=%3Cproquest_highw%3E70194482%3C/proquest_highw%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=232314361&rft_id=info:pmid/17971515&rfr_iscdi=true |